ARCHIVES

President Signs Supplemental Funding For NIH And FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Puts Clinical Hold On Gene Therapy Trials

January 24, 2003

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

June 14, 2002

DeVita Seeks End to Funding For CROS, Reacts With Anger To Charge Of “Central Direction From Washington”

February 20, 1981

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002